Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylthioninium chloride sustained-release tablets to assist colonoscopy for colorectal adenoma screening
ChiCTR2500107847Phase 4Not yet recruiting
- Sponsor
- The Second Hospital of Hebei Medical University
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of methylene blue in colon adenoma, Sessile Serrated Lesion (SSL) and colonic polyp (2 arms), sponsored by The Second Hospital of Hebei Medical University. Primary endpoint: Adenoma detection rate. Planned start Aug 2025; status: not yet recruiting.
02
Drugs
methylene blue
03
Conditions
colon adenomaSessile Serrated Lesion (SSL)colonic polyp
Beyond the preview
Go deeper on ChiCTR2500107847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500107847.